Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2020
Schedule of Pharmaceutical Benefits - 1 September 2020 update
1 September 2020 - The September 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Aug 2020
New hope for Australian leukaemia and lymphoma patients with key treatment option listed on PBS
31 August 2020 - A key new cancer treatment has just become more accessible for Australians fighting specific forms of leukaemia ...
Posted by Michael Wonder on 26 Aug 2020
Insights from the agenda for the November 2020 PBAC meeting
26 August 2020 - New gene therapy from Novartis the standout submission from version 1. ...
Posted by Michael Wonder on 26 Aug 2020
Agenda for the November 2020 PBAC meeting
26 August 2020 - The agenda for the November 2020 PBAC meeting is now available. ...
Posted by Michael Wonder on 23 Aug 2020
Prostate cancer treatment Nubeqa made available for free in Australia by Bayer
23 August 2020 - Prostate cancer kills more than 3,000 men a year in Australia. But now many will have access ...
Posted by Michael Wonder on 21 Aug 2020
Simplified prescribing arrangements for chemotherapy patients during the COVID-19 pandemic
21 August 2020 - Amendments to the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 and the establishment of ...
Posted by Michael Wonder on 02 Aug 2020
Schedule of Pharmaceutical Benefits - 1 August 2020
1 August 2020 - The August 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Aug 2020
Australians with cancer, infants with epilepsy to benefit from PBS listings
1 August 2020 - Australians with certain cancers and infants with severe epilepsy will benefit from new medications being listed or ...
Posted by Michael Wonder on 29 Jul 2020
Electronic prescriptions to revolutionise health care
29 July 2020 - Patients will soon be able to have a script issued and filled without leaving their homes, with ...
Posted by Michael Wonder on 28 Jul 2020
2020 October price disclosure cycle – indicative prices
28 July 2020 - Indicative 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 27 Jul 2020
Biosimilar insulin glargine on the PBS - information for health professionals and patients
27 July 2020 - Changes have been made from 1 July 2020 to the PBS listings for insulin glargine, as the ...
Posted by Michael Wonder on 23 Jul 2020
PBAC statement of endorsement for transparency measures and standardised redactions to public summary documents
23 July 2020 - The PBAC has made a statement outlining its support for measures to improve the transparency of ...
Posted by Michael Wonder on 19 Jul 2020
PBAC asks Roche for another comparison for Tecentriq
20 July 2020 - The submission requested a PBS (Section 100) listing for atezolizumab for use in combination with taxane chemotherapy ...
Posted by Michael Wonder on 17 Jul 2020
Public Summary Documents - March 2020 meeting
17 July 2020 - The Public Summary Documents (first time rejections and deferrals) from the March 2020 PBAC meeting are now ...
Posted by Michael Wonder on 16 Jul 2020
Mallinckrodt and Terumo BCT announce positive recommendations for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos CE
13 July 2020 - In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement ...